Primary Myelofibrosis
Showing NaN - NaN of 12
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)
Recruiting
- Myeloproliferative Disorders
- +4 more
- ACE-536
- Placebo
-
La Jolla, California
- +184 more
Aug 22, 2022
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +2 more
-
Phoenix, Arizona
- +61 more
May 5, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Momelotinib
- +3 more
-
Phoenix, Arizona
- +166 more
Jan 27, 2022
Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +2 more
-
Vienna, Austria
- +19 more
Apr 28, 2020
Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)
Completed
- Primary Myelofibrosis
- +9 more
-
Camperdown, New South Wales, Australia
- +17 more
Apr 3, 2020
Primary Myelofibrosis, MPN-associated Myelofibrosis Trial in Worldwide (Pomalidomide 0.5 mg, Placebo, Pomalidomide)
Completed
- Primary Myelofibrosis
- MPN-associated Myelofibrosis
- Pomalidomide 0.5 mg
- +2 more
-
Scottsdale, Arizona
- +86 more
Jun 24, 2019